ASCO launches TAPUR trial

The American Society of Clinical Oncology launched the Targeted Agent and Profiling Utilization Registry (TAPUR) trial, a study of off-label uses of targeted therapies. TAPUR will

Read the full 265 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE